Study of the Effect on Clinical Outcomes Using Secure Text Messaging

Diabetes Clinical Trial

Official title:

Study of the Effect on Clinical Outcomes Using Secure Text Messaging

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT02568514
• Other study ID #: 823096
• Status: Withdrawn
• Phase: N/A
• First received: October 2, 2015
• Last updated: April 6, 2017
• Start date: August 2016
• Est. completion date: March 2017

Study information

• Verified date: April 2017
• Source: University of Pennsylvania
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.

Description:

Inpatient health care providers such as physicians and nurses spend up to one-third of their time communicating with other health care providers. Many of these communications have shifted mediums from handwritten notes and face-to-face conversations to phone calls and paging systems. More recently the rapid adoption of smartphones has led to the use of mobile-enabled technologies using smartphones such as text messaging and email. While these technologies may offer ease and fit better within the clinical workflow, they often send patient information through unsecure cellular or internet connections. Mobile secure text messaging may address these issues by encrypting data and allowing for asynchronous or synchronous communication between individual providers or groups of providers. In this study, the investigators will conduct a randomized, controlled trial to evaluate the impact of offering mobile secure text messaging on clinical outcomes.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: March 2017
• Est. primary completion date: March 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Admission to one of the hospital floors or services in the study at the Hospital of the University of Pennsylvania

Exclusion Criteria:

• Discharges against medical advice

• Discharges to hospice

Related Conditions & MeSH terms

• Congestive Heart Failure
• Copd
• Diabetes
• Heart Failure
• Renal Failure
• Renal Insufficiency

Intervention

Device:
• Secure text messaging
A smartphone and web application that allows physicians and other health care professionals to communicate to each other by secure text message

Locations

Country	Name	City	State
United States	University of Pennsylvania	Philadelphia	Pennsylvania

Sponsors (1)

Lead Sponsor	Collaborator
University of Pennsylvania

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in length of stay	Change in inpatient length of stay from baseline to 6 months	6 months
Primary	Change in 30 day hospital readmissions	Change in 30 day hospital readmissions from baseline to 6 months	6 months
Primary	Change in inpatient mortality	Change in inpatient mortality from baseline to 6 months	6 months
Secondary	Change in Hospital Consumer Assessment of Healthcare Providers and Systems (HCAPs) scores	Change in HCAP scores from baseline to 6 months	6 months